Camfetamine (N-methyl-3-phenyl-norbornan-2-amine) is a stimulant drug closely related to the appetite suppressant fencamfamine, being its N-methyl homologue.[1] It has been sold as a designer drug following the banning of mephedrone and related substituted cathinone derivatives in many countries,[2] and reportedly has slightly stronger stimulant effects than fencamfamine, but with correspondingly more severe side effects.

Camfetamine
Clinical data
ATC code
  • none
Identifiers
  • N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine
CAS Number
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19N
Molar mass201.313 g·mol−1
3D model (JSmol)
  • C2CC1CC2C(NC)C1c3ccccc3
  • InChI=1S/C14H19N/c1-15-14-12-8-7-11(9-12)13(14)10-5-3-2-4-6-10/h2-6,11-15H,7-9H2,1H3
  • Key:CTVMYAZECFXZLN-UHFFFAOYSA-N

See also

edit

References

edit
  1. ^ DE patent 1110159, Thesing J, Seitz G, Hotovy R, Sommer S, "Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate bzw. von deren Säureadditionssalzen und quaternären Ammoniumverbindungen", issued 1961-07-06, assigned to E. Merck AG 
  2. ^ Kavanagh P, Angelov D, O'Brien J, Power JD, McDermott SD, Talbot B, et al. (April 2013). "The synthesis and characterization N-methyl-3-phenyl-norbornan-2-amine (Camfetamine™)". Drug Testing and Analysis. 5 (4): 247–53. doi:10.1002/dta.411. PMID 22374810.